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SAP is an adaptor protein that is expressed in NK and T cells. It is mutated in humans who 
have X-linked lymphoproliferative (XLP) disease. By interacting with SLAM family receptors, 
SAP enables tyrosine phosphorylation signaling of these receptors by its ability to recruit the 
Src-related kinase, Fyn. Here, we analyzed the role of SAP in NK cell functions using the 
SAP-deficient mouse model. Our results showed that SAP was required for the ability of NK 
cells to eliminate tumor cells in vitro and in vivo. This effect strongly correlated with 
expression of CD48 on tumor cells, the ligand of 2B4, a SLAM-related receptor expressed in 
NK cells. In keeping with earlier reports that studied human NK cells, we showed that SAP 
was necessary for the ability of 2B4 to trigger cytotoxicity and IFN-
 
 
 
 secretion. In the 
absence of SAP, 2B4 function was shifted toward inhibition of NK cell–mediated 
cytotoxicity. By analyzing mice lacking Fyn, we showed that similarly to SAP, Fyn was 
strictly required for 2B4 function. Taken together, these results provide evidence that the 
2B4-SAP-Fyn cascade defines a potent activating pathway of natural cytotoxicity. They also 
could help to explain the high propensity of patients who have XLP disease to develop 
lymphoproliferative disorders.
 
NK cells are potent effector cells of innate
immunity by their ability to eliminate tumor
cells and virus-infected cells. The effector func-
tions of NK cells are controlled by activating
and inhibitory receptors (1–3) that are engaged
during the recognition of potential target cells.
The pathways that activate natural cytotoxicity
have not been elucidated completely. The
C-lectin like receptor, NKG2D, plays an essen-
tial role in NK cell–mediated rejection of tumor
cells, even if those cells have normal MHC
class I expression. NKG2D recognizes “stress-
induced” MHC class I–related molecules that
are strongly up-regulated during infection or
cell transformation. However, a number of
tumor cells do not express NKG2D ligands,
which suggest that NK cell–mediated antitu-
moral immunity may be activated by other
ligand–receptor interactions (4, 5).
Activating NK cell receptors, such as natural
cytotoxicity receptors, activating forms of killer
Ig-like receptors, CD94-NKG2C, NKG2E,
Ly49D, Ly49H, and Ly49P in mice, also are
postulated to play an important role in the acti-
vation of natural cytotoxicity (1–3). However,
recent analyses of DAP-12–deficient mice,
CD3-
 
 
 
/FcR-
 
 
 
-deficient mice, and Syk/Zap-
70–deficient mice provided compelling evi-
dence that immunoreceptor tyrosine-based ac-
tivation motif (ITAM)-dependent signaling
pathways are not essential for natural cytotoxicity
against a number of tumor cells, suggesting the
existence of alternative pathways (6–8).
2B4 is another activating receptor that is
expressed on human and mouse NK cells. 2B4
belongs to the CD2/SLAM family of immune
cell receptors (3, 9). In mice and humans, liga-
tion of 2B4 by anti-2B4 antibodies triggers
NK cell–mediated cytotoxicity and IFN-
 
 
 
production (10, 11). The ligand for 2B4 is
CD48, which also belongs to the CD2/SLAM
family of receptors (9, 12). CD48 is expressed
on B cells and T cells and its expression increases
upon cell activation (12, 13). In humans, trans-
fection of CD48 in target cells increases their lysis
by NK cells (14, 15). However, direct evidence
that 2B4 activates natural cytotoxicity in vivo
is missing.
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2B4-mediated NK cell activation does not involve DAP-
10 or ITAM-containing subunits. When phosphorylated on
tyrosine, 2B4 associates with the small adaptor molecule SAP
(16, 17). SAP is composed almost exclusively of a unique
Src-homology 2 domain that associates with TIYxxV/I mo-
tifs found in the cytoplasmic domains of the SLAM family
receptors (9, 18). In T lymphocytes, SAP is required for the
function of the SLAM receptor (19). In this context, SAP
behaves as an adaptor protein by promoting the selective re-
cruitment of the Src-related kinase Fyn to SLAM. Recently,
it was shown that SAP also could promote the recruitment
of Fyn to 2B4 in NK cells (20). However, it is not known
whether Fyn is required for the function of 2B4.
Evidence that SAP plays a key role in in vivo immune
responses was provided by the finding that mutations in the
 
SH2D1A
 
 gene encoding SAP caused X-linked lymphopro-
liferative (XLP) syndrome (9). XLP is an inherited fatal im-
mune dysfunction of lymphocyte homeostasis that is char-
acterized principally by an inappropriate immune response
to EBV infection that leads to a massive and uncontrolled
lymphoproliferation of CD8
 
 
 
 T cells and macrophages (21,
22). If children survive this initial episode or are asymptom-
atic, they generally go on to develop aggressive lympho-
proliferative disorders, such as lymphomas. However, the
physiopathology of XLP is unclear. Abnormalities in NK
cell–and T cell–mediated cytotoxicity responses have been
reported (21, 23, 24). Given the crucial role of cytotoxic
functions in lymphocyte homeostasis and antitumoral re-
sponses, defects in this machinery could contribute to the
lymphoproliferation disorders that are observed in XLP
(25). Recent studies of NK cells from humans who had
XLP showed that 2B4-mediated cytotoxicity is impaired in
the absence of SAP; this highlighted the crucial role of SAP
in the signal transduction and the function of 2B4 (14, 16,
17). Whether similar defects exist in SAP-deficient mice
has not been investigated.
In light of these observations, we took advantage of
SAP-deficient mice and Fyn-deficient mice to examine the
exact function of SAP in natural cytotoxicity, and to define
the signaling pathways in NK cells in which SAP is involved.
We showed that a 2B4/SAP/Fyn pathway is required for
antitumoral natural cytotoxicity.
Figure 1. In vivo and in vitro natural killing responses are impaired 
in SAP-deficient mice. (A) The elimination of tumor cells in vivo is impaired 
in SAP  mice. SAP  and SAP  mice were injected intraperitoneally with 
PKH-26–labeled RMA cells (106). After 24 h, the numbers of residual RMA 
cells recovered from the peritoneal cavity of SAP  and SAP  mice were 
determined by cytometry (see Materials and methods). The data presented 
are pooled from three independent experiments. Bars indicate mean val-
ues for each group of mice. (B) Natural cytotoxicity in vitro against a panel 
of target cells is restricted in SAP-deficient NK cells. The cytolytic activity 
of IL-2–expanded splenic NK cells from SAP  ( ) and SAP  ( ) mice was 
tested against the indicated target cells, at the mentioned NK/target cells 
ratios. For each target, data are presented as means from one experiment 
representative of three independent experiments. 
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RESULTS
Natural cytotoxicity in SAP-deficient NK cells
 
Because previous studies reported that patients who had XLP
disease could present abnormalities in NK cell–mediated cy-
totoxicity, we investigated the natural cytotoxicity response
in SAP
 
-
 
deficient mice. We first examined NK cell popula-
tions in the spleen, bone marrow, liver, and thymus of SAP-
deficient mice (hereafter referred to as 
 
SAP
 
 
 
 mice) and
wild-type littermates (hereafter referred to as 
 
SAP
 
 
 
 mice;
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20050449/DC1). The percentages of CD3
 
 
 
NK1.1
 
 
 
 NK
cells in the various organs of 
 
SAP
 
 
 
 mice were comparable to
those observed in their 
 
SAP
 
 
 
 littermates, and the expression
profiles of 2B4, Ly49G2, Ly49D, Ly49A, Ly49C/I, and
CD16 (Fc
 
 
 
RIII) on splenic NK cells were similar in 
 
SAP
 
 
 
and 
 
SAP
 
 
 
 mice. Therefore, SAP seems to be dispensable for
the development of NK cells. The elimination of tumor cells
is one of the major functions attributed to NK cells. Anti-
tumoral NK activity can be evaluated in vivo by injecting tu-
mor cells into the peritoneal cavity of mice. When injected
into the peritoneal cavity, RMA lymphoma cells are elimi-
nated by NK cells (6). Therefore, we evaluated the capacity
of 
 
SAP
 
 
 
 NK cells to eliminate RMA tumor cells in vivo.
RMA cells that were labeled with PHK 26 could be detected
readily among peritoneal exudate cells by cytometry based on
their PKH 26 fluorescence (unpublished data). The percent-
age of RMA cells was determined and the number of RMA
cells recovered from the peritoneal cavity was calculated (Fig.
1 A). In the control 
 
SAP
 
 
 
 mice (
 
n 
 
 
 
 8), 30 
 
 
 
 15 
 
 
 
 10
 
3
 
RMA cells were recovered, whereas 134 
 
 
 
 26 
 
 
 
 10
 
3
 
 RMA
cells were recovered from 
 
SAP
 
 
 
 mice (
 
n 
 
 
 
 5). Thus, 
 
SAP
 
 
 
mice eliminated RMA cells much less efficiently than wild-
type mice (P 
 
 
 
 0.001). This strongly suggests that antitu-
moral NK activity is impaired in 
 
SAP
 
 
 
 mice.
Figure 2. SAP is required for 2B4-mediated cell cytotoxicity and 
IFN-  production by NK cells. (A) Association of SAP with 2B4 in mouse 
NK cells. IL-2–expanded splenic NK cells were treated ( ) or not treated 
( ) with pervanadate (PV) for 10 min. 2B4 was immunoprecipitated (I.P.) 
and subjected to immunoblotting with anti-Ptyr antibody (top), anti-2B4 
antibodies (middle), or anti-SAP antibodies (bottom). Total cell lysates 
were assessed in parallel. (B) The 2B4-mediated cytolytic activity by NK 
cells is impaired in the absence of SAP. The cytolytic activity of IL-2–
expanded NK cells from SAP  (left) and SAP  (right) mice was measured 
in a redirected antibody-dependent cell-cytotoxicity assay. NK cells were 
incubated with the FcR  P815 target cells in the presence of anti-2B4, 
anti-Ly49D, anti-NK1.1 antibodies or medium (no Ab) at the indicated 
NK/target cell ratios. Data are presented as means from one representative 
experiment of three independent experiments. (C and D) 2B4-mediated 
IFN-  production by NK cells is impaired in the absence of SAP. IFN-  in 
the cell-supernatants was detected by ELISA. (C) NK cells from SAP  and 
SAP  mice were incubated with increased concentrations of anti-2B4 
antibodies in the presence of FcR  P815 cells to trigger antibody-
redirected stimulation of NK cells. Data are means from one representa-
tive experiment of two independent experiments. (D) IL-2–expanded NK 
cells from SAP  and SAP  mice were stimulated with medium, soluble 
anti-2B4 antibodies; irrelevant antibodies of the same isotype; or IL-12. 
Data are means   SD from one representative experiment of three 
independent experiments. 
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To characterize this defect further, we evaluated the cy-
tolytic activity of IL-2–expanded splenic NK cells from 
 
SAP
 
 
 
and 
 
SAP
 
 
 
 mice toward various tumor cell lines in vitro. Con-
sistent with the in vivo data (Fig. 1 A), 
 
SAP
 
 
 
 NK cells
showed an impaired cytolytic activity against RMA cells when
compared with 
 
SAP
 
 
 
 NK cells (Fig. 1 B). Similarly, the ca-
pacity of 
 
SAP
 
 
 
 NK cells to lyse YAC-1, RMA/S, BW15.02,
Ba/F3, EL4, and C4.4-25 tumor cell targets also was reduced
(Fig. 1 B). In particular, the cytolytic activity involved in the
killing of RMA, Ba/F3, and EL-4 was abolished almost com-
pletely in the absence of SAP. By contrast, the ability of 
 
SAP
 
 
 
NK cells to lyse B16-FO, IC-21, CHO, and P815 cells was
comparable to that of 
 
SAP
 
 
 
 NK cells (Fig. 1 B; see Fig. 2 B).
C4.4.25 and RMA/S cells are MHC class I negative and low
derivatives from EL4 and RMA cells, respectively (8). The
lack of MHC class I expression renders C4.4.25 and RMA/S
cells more susceptible to NK cell lysis. However, the killing of
all of these cells was dependent on SAP, regardless of their ex-
pression of MHC class I. Together, these results indicate that
the natural cytotoxicity of 
 
SAP
 
 
 
 NK cells against tumor cells
is restricted. Thus, SAP is required for some forms of NK
cell–mediated cytotoxicity against tumor cells, including those
that expressed MHC class I molecules.
 
2B4 functions in SAP-deficient NK cells
 
In human NK cells, SAP was shown to bind to tyrosine
phosphorylated 2B4 and to be required for 2B4-mediated
NK cell cytotoxicity (14, 16, 17). We first ascertained that
SAP also bound with 2B4 in mouse NK cells. To this end,
IL-2–expanded splenic NK cells were stimulated with the
tyrosine phosphatase inhibitor, pervanadate, which has been
used to demonstrate the association of SAP with 2B4 in hu-
man NK cells (16, 17, 26). In pervanadate-treated NK cells,
2B4 exhibited a strong increase in its phosphotyrosine con-
tent as compared with that in nonstimulated NK cells (Fig. 2
A, top, lanes 1 and 2). However, a weak tyrosine phosphor-
ylation of 2B4 was detected in unstimulated NK cells (lane
1). A parallel anti-SAP immunoblot revealed that 2B4 was
associated with SAP in nonstimulated cells (Fig. 2, bottom,
lane 1). Upon pervanadate treatment, the extent of the 2B4-
SAP association was enhanced strongly (Fig. 2, bottom, lane
2). Reblotting with anti-2B4 antibodies showed that similar
amounts of 2B4 polypeptides were recovered by immuno-
precipitation in nonstimulated and in pervanadate-stimulated
cells (Fig. 2, middle, lanes 1 and 2). Thus, our results
strongly suggest that in mouse NK cells, 2B4 is associated
with SAP in a tyrosine phosphorylation–dependent manner.
We then investigated whether SAP was required for 2B4-
mediated cell cytotoxicity of IL-2–expanded splenic NK cells.
We assessed 2B4-mediated cell cytotoxicity by redirected (or
reverse) antibody-dependent cell cytotoxicity (RADCC) as-
says, using the FcR
 
 
 
 P815 mastocytoma cell line as target
cells. Cross-linking of 2B4 with anti-2B4 antibodies enhanced
the lysis of P815 cells by 
 
SAP
 
 
 
 NK cells (Fig. 2 B, left), but it
failed to enhance P815 killing by 
 
SAP
 
 
 
 NK cells over the
magnitude obtained in the absence of antibodies (right). The
lysis of P815 cells was inhibited slightly, albeit significantly, by
2B4 stimulation in these conditions. In a related manner, we
and others have observed a similar inhibitory effect in testing
human NK cells that lack SAP (unpublished data; reference
16). However, the stimulation of activating NK receptors,
such as NK1.1, Ly49D, and CD16 (unpublished data), on
 
SAP
 
 
 
 NK cells resulted in an increase in P815 lysis similar in
intensity to that obtained with 
 
SAP
 
 
 
 NK cells. Thus, SAP is
not required for the activating pathways that are triggered by
NKR-P1c, CD16, and Ly49D receptors, which are known
to depend on ITAM-containing subunits (1).
Because 2B4 ligation also triggers IFN-
 
 
 
 production by
NK cells, we next examined whether SAP was required for this
function. The stimulation of 
 
SAP
 
 
 
 NK cells with P815 target
cells in the presence of increasing concentrations of 2B4 anti-
bodies resulted in a marked accumulation of IFN-
 
 
 
 in the cell
supernatant (Fig. 2 C). In contrast, this response was impaired
severely with 
 
SAP
 
 
 
 NK cells. Consistent with earlier reports
(10, 11), the stimulation of 
 
SAP
 
 
 
 NK cells with soluble anti-
2B4 antibodies also increased IFN-
 
 
 
 secretion when compared
with cells that were stimulated with control antibodies (Fig. 2
D). In contrast, IFN-
 
 
 
 production in response to soluble anti-
2B4 antibodies was abolished almost completely in 
 
SAP
 
 
 
 NK
cells. Despite these differences, 
 
SAP
 
 
 
 and 
 
SAP
 
 
 
 NK cells dis-
played similar levels of IFN-
 
 
 
 production following stimula-
tion with IL-12 (Fig. 2 D). Taken together, these observations
clearly show that in mice, SAP is required for 2B4-mediated
cell cytotoxicity and IFN-
 
 
 
 production by NK cells.
 
Regulation of natural cytotoxicity by CD48 expression 
on tumor cells
 
Because 2B4-mediated cytotoxicity is abolished in 
 
SAP  NK
cells, we considered that the loss-of-function of 2B4 might ac-
count for the natural cytotoxicity defect in SAP  NK cells. In
this case, only target cells killed less efficiently by SAP  NK
cells would be expected to express CD48, the 2B4 ligand (12).
To address this issue, the various target cell lines were exam-
ined by flow cytometry for CD48 expression. Expression of
CD48 was detected readily on the membrane of YAC-1,
EL4, C4.4-25, RMA, RMA-S, Ba/F3, and BW15.02 cells
(Fig. 3), all of which were found to be lysed by a SAP-depen-
dent NK cell cytotoxicity (Fig. 1). Conversely, no CD48 ex-
pression was detected on P815, B16-FO, IC-21, or CHO tar-
get cells (Fig. 3), the killing of which by NK cells does not
require SAP (Fig. 1 B). Hence, CD48 expression on tumor
cell lines seems to be related to the impaired capacity of SAP 
NK cells to kill those cells. Therefore, these data strongly sug-
gest that the impaired natural cytotoxicity response in SAP 
mice is caused by a defect of 2B4-mediated cytotoxicity.
Because the results reported above were purely correlative,
we wished to address the role of CD48 expression directly on
target cells in SAP-dependent killing. To this end, C4.4-25
cells were cloned by limiting dilution, and we obtained two
monoclonal cell lines that did not express CD48 (hereafter re-JEM VOL. 202, July 4, 2005 185
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ferred to as CL.1 and CL.52) as shown by flow cytometry anal-
ysis (Fig. 4 A). When used as target cells with SAP  NK cells,
CL.1 and CL.52 were lysed less efficiently than the parental
C4.4-25 cells (Fig. 4 B). Thus, the loss of CD48 expression on
C4.4-25 target cells decreased their susceptibility to 2B4-medi-
ated NK cell cytotoxicity. However, we could not exclude for-
mally that the possibility that this decrease was caused by
CD48-independent events that were selected for during the
cloning process. To rule out this possibility, a mouse cDNA
that encoded the C57BL/6 allelic form of CD48 was intro-
duced into CL.1 and CL.52 cells by electroporation. Polyclonal
populations that stably expressed CD48 were produced (hereaf-
ter referred to as CL.1-CD48 and CL.52-CD48) as depicted in
Fig. 5 A. The lysis of these cell lines by SAP  NK cells was
compared with that of the parental CD48-deficient CL.1 and
CD48-deficient CL.52 cells. The killing of CL.1-CD48 and
CL.52-CD48 cells by SAP  NK cells was greater than that of
the CD48-deficient CL.1 and CL.52 cells (Fig. 5 B).
We next investigated whether SAP was required for the
NK cell cytotoxicity induced by CD48 expression on CL.1-
CD48 and CL.52-CD48 cells. The lysis of CL.1-CD48 and
CL.52-CD48 cells and their CD48-deficient parental cells by
SAP  NK cells was examined. SAP  NK cells lysed CL.1-
CD48 and CL.52-CD48 much less efficiently than did SAP 
NK cells. In comparison, CL.1 and CL.52 cells were lysed to
a similar extent by SAP  NK cells and SAP  NK cells.
When compared with CL.1 and CL.52, the killing of CL.1-
CD48 and CL.52-CD48 by SAP  NK cells was diminished
markedly, whereas it was increased with SAP  NK cells. This
inhibition was consistent with the data presented in Fig. 2 B,
which showed that the stimulation of 2B4 with anti-2B4 an-
tibodies inhibited NK cell cytotoxicity of SAP  NK cells.
Based on these results, we conclude that expression of
CD48 on tumor cells increases their susceptibility to lysis by
NK cells via a 2B4/SAP-dependent activating pathway. In
addition, these data indicate that in the absence of SAP, the
engagement of 2B4 by its ligand, CD48, on target cells re-
sults in the inhibition of NK cell cytotoxicity, as suggested
previously by the analysis of human SAP  NK cells (16).
In vivo elimination of CD48-expressing tumor cells
We then evaluated the role of CD48 expression on tumor cells
in vivo during the NK cell antitumoral response. For this pur-
pose, in vivo elimination of CL.1 and CL.1-CD48 tumor cells
was examined in the peritoneal cavity of various strains of mice.
Like the parental C4.4-25 cells, CL.1 and CL.1-CD48 cells do
not express MHC class I molecules, and accordingly, are elimi-
nated rapidly in the peritoneal cavity by NK cells (not depicted
and Fig. 6). Equal numbers of carboxyl fluorescein succinimidyl
ester (CFSE)-labeled CL.1 and CL.1-CD48 cells were mixed
and injected intraperitoneally into normal SAP  mice.
1 h after injection into normal SAP  mice, the propor-
tions of CL.1 and CL.1-CD48 cells in the peritoneal cavity
Figure 3. Cell surface expression of CD48, the 2B4 ligand, on 
target cell lines. Cell surface expression of CD48 was assessed by flow 
cytometry with anti-CD48 and FITC-conjugated anti–rat Ig (thick histo-
gram). Controls were stained with FITC-conjugated anti–rat Ig alone 
(thin histogram).
Figure 4. The lack of CD48 expression on tumor cells decreases the 
susceptibility of these cells to be killed by NK cells in vitro. (A) CD48 
is not expressed on CL.1 and CL.52 cells which were derived from C4.4-25 
cells (see Materials and methods). CD48 expression was assessed as in Fig. 
3. (B) Lysis of CL.1 and CL.52 by NK cells. The cytolytic activity of IL-2–expanded 
splenic NK cells was tested against CL.1, CL.52, or the parental C4.4-25 
target cells, at the indicated NK/target cell ratios. Data are presented as 
means from one experiment representative of three independent experiments.CONTROL OF NATURAL CYTOTOXICITY BY SAP | Bloch-Queyrat et al. 186
were similar to those in the original cell mixture, maintained
in culture for the same period of time (unpublished data). By
contrast, after 6 h, the proportion of CL.1-CD48 cells
among the CFSE-labeled peritoneal cells had decreased sig-
nificantly (Fig. 6 A). This decrease could not be explained by
different rates of division of CL.1 and CL.1-CD48 cells be-
cause the proportions of these two types of cell remained
unchanged in the noninjected cell mixture that was main-
tained in culture for 6 h (Fig. 6 A). Combined with the data
from in vitro cytotoxicity assays (Fig. 5), this decrease likely
reflects a more efficient in vivo killing of CL.1-CD48 cells as
compared with CL.1 cells. Consistent with that, the absolute
number of CL.1-CD48 cells (49.4   30   103; n   8) that
was recovered in the peritoneal cavity was much lower than
the number of CL.1 cells that was recovered (297.2  
97.5   103; n   5; P   0.0038; Fig. 6 B). Therefore, these
observations suggest that CD48 expression on tumor cells
increases the elimination of these cells in vivo.
To ascertain the role of NK cells in this response, the
same experiments were performed in T/B cell–deficient
RAG-2 /  and T/B/NK cell–deficient RAG-2 /  c / 
mice. In RAG-2 /  mice, the proportion of CL.1-CD48
cells was shown to be decreased to a similar extent to that
observed in control SAP  mice (Fig. 6 A). The number of
CL.1-CD48 cells recovered from RAG-2 /  mice (34.5  
3.5   103, n   2) did not differ significantly from that ob-
tained from SAP  mice (49.4   30   103, n   8; Fig. 6 B).
Thus, T and B lymphocytes are not required for the elimina-
tion of CD48-expressing tumor cells. By contrast, in RAG-
2 /  c /  mice, which lack B, T, and NK cells, the propor-
tion of CL.1-CD48 cells was only slightly lower than the
initial proportion of CL.1-CD48 cells in the control cell
mixture that was not injected. In agreement with these data,
the number of CL.1-CD48 cells found in the peritoneal cav-
ity of RAG-2 /  c /  mice (221.6   104.6   103, n   5)
was larger than that in control SAP  mice (49.4   30   103;
n   8; P   0.001). Thus, the elimination of CL.1-CD48
cells in the peritoneal cavity primarily depends on NK cells.
We assessed the elimination of CL.1 and CL.1-CD48 cells
in SAP  mice. CL.1-CD48 cells were eliminated much less
efficiently in SAP  mice than in normal SAP  mice (Fig. 6
A). Consistent with these data, more CL.1-CD48 cells
(248.7   87.8   103, n   6) were recovered from the perito-
neal cavity in SAP  mice than in SAP  mice (49.4   30  
103, n   8; P   0.0013; Fig. 6 B). By contrast, the numbers of
CL.1 cells collected from SAP  mice (429.6   14   103, n   4)
and SAP  mice (297.2   97.5   103, n   5) did not differ
significantly. These results are consistent with those of the cy-
totoxicity assays in vitro shown in Fig. 5. Lastly, the propor-
tion of CL.1-CD48 cells in SAP  mice was very similar to
that observed in RAG-2 /  c /  mice, and the number of
CL.1-CD48 cells found in SAP  mice was not significantly
different from that in RAG-2 /  c /  mice. To exclude that
these effects were caused by a defect in the recruitment of NK
cells in the peritoneal cavity of SAP  mice, the number of
peritoneal NK cells was evaluated after injection of CL.1 and
CL.1-CD48 cells. NK cells in the peritoneal fluid were de-
tected by flow cytometry based on their expression of NK1.1
Figure 5. Influence of SAP expression on NK cell–mediated cyto-
toxicity toward CD48-expressing tumor cells. (A) Cell surface expression 
of CD48 in CL.1 and CL.52 cells stably transfected with a cDNA encoding 
CD48. Experiment same as in Fig. 4. (B and C) The expression of CD48 on 
tumor cells enhanced the susceptibility of these cells to be killed by SAP  
NK cells, whereas it inhibited the killing of these cells by SAP  NK cells. The 
cytolytic activity of IL-2–expanded splenic NK cells from SAP  (B) and 
SAP  (C) mice was tested in parallel against CL.1, CL.52, CL.1-CD48, or 
CL.52-CD48 target cells at the indicated NK/target cell ratios. For each 
target, data are presented as means from one representative experiment 
of three independent experiments.JEM VOL. 202, July 4, 2005 187
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and 2B4 and their lack of CD3 expression. CL.1 and CL.1-
CD48 cells did not express 2B4 and NK1.1 (unpublished
data). Injection of CL.1 and CL.1-CD48 cells in SAP  mice
resulted in a significant increase in the number of peritoneal
2B4 NK1.1 CD3  NK cells (47.6   27   103, n   9) when
compared with that observed in mice injected with PBS alone
(16.3   6.9   103, n   6, P   0.004). However, the number
of 2B4 NK1.1 CD3  cells found in the peritoneal cavity of
SAP  mice (34.2   25.5   103, n   6) after injection of
CL.1 and CL.1-CD48 cells was not significantly different
from that observed in SAP  mice (P   0.47). This result indi-
cates that the defect in the elimination of CL.1-CD48 cells in
SAP  mice did not result from a reduced recruitment of NK
cells in the peritoneal cavity. Collectively, these data clearly
demonstrate that the elimination of CL.1-CD48 cells by NK
cells is dependent on SAP. They also suggest that 2B4-medi-
ated NK cell cytotoxicity is involved in the in vivo elimina-
tion of tumor cells expressing CD48.
2B4-mediated natural cytotoxicity in Fyn-deficient mice
We recently provided evidence that SAP could promote the
recruitment of Fyn to 2B4 (20). Hence, we examined whether
Fyn was required for 2B4-mediated natural cytotoxicity and
IFN-  production. IL-2–expanded splenic NK cells from
Fyn-deficient mice were obtained. In RADCC, cross-linking
of 2B4 with anti-2B4 antibodies failed to enhance P815 killing
by IL-2–expanded splenic NK cells from Fyn-deficient mice
when compared with wild-type NK cells. However, killing of
P815 lysis by Fyn-deficient NK cells after stimulation with
anti-Ly49D (Fig. 7 A) or anti-NK1.1 (not depicted) antibodies
was not affected, whereas it was decreased partially upon stim-
ulation with anti-CD16. This is consistent with the notion
that CD16-mediated NK cell activation depends on Fyn and
Lck Src-kinases (27). 2B4-mediated IFN-  production also
was defective in Fyn-deficient NK cells (Fig. 7 B). Killing of
CD48-positive target cells, such as C4.4-25, RMA/S, and
RMA cells, by Fyn-deficient NK cells was impaired strongly
(Fig. 7 C). By contrast, the lysis of the CD48-negative CHO
target cells was not affected. Finally, the expression of CD48
on CD48-CL.1 cells failed to enhance their killing by Fyn-
deficient NK cells as compared with CL.1 cells that lack CD48
(Fig. 7 D). These data demonstrate that like SAP, Fyn is re-
quired for 2B4-mediated natural cytotoxicity.
2B4-mediated tyrosine phosphorylation in SAP-deficient 
and Fyn-deficient NK cells
To characterize further the defect in 2B4-mediated natural cy-
totoxicity in SAP-deficient and Fyn-deficient mice, the capac-
Figure 6. Increase in the in vivo elimination of CD48-expressing 
tumor cells by NK cells. SAP , SAP , RAG-2 /  and RAG-2 /  c /  
mice were injected intraperitoneally with a mixture of equal numbers of 
CFSE-labeled CL.1 and CFSE-labeled CL.1-CD48 tumor cells. After 6 h, 
peritoneal cells were recovered, counted, and stained with PE-conjugated 
anti-CD48 antibody. An aliquot of the cell mixture was kept in culture for 
6 h (noninjected). (A) The percentages of CL.1 and CL.1-CD48 tumor cells 
in the CFSE-positive cell population were evaluated by flow cytometry, 
based on CD48 fluorescence. Representative dot-plots of gated CFSE-
positive cells are shown and the injected mice are indicated. (B) Numbers 
of residual CL.1 cells and CL.1-CD48 cells recovered from the peritoneal 
cavity of SAP , SAP , RAG-2 / , and RAG-2 /  c /  mice. The data pre-
sented are pooled from four independent experiments. One experiment in 
which only CL1-CD48 cells were injected is included. Bars indicate mean 
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ity of 2B4 to trigger tyrosine phosphorylation signals was ex-
amined (Fig. 8). Stimulation of wild-type NK cells with anti-
2B4 antibodies increased the tyrosine phosphorylation levels
of several intracellular proteins, including a p70 and a p150 kD
(Fig. 8 A). In Fyn-deficient mice this signal was completely
abolished, whereas it was decreased markedly in SAP-deficient
mice. As described previously (20), the major substrates that
were phosphorylated upon 2B4 engagement in wild-type NK
cells were 2B4 itself (Fig. 8 B, top) and the inositol phos-
phatase, SHIP (Fig. 8 B, middle; lanes 1 and 2). In contrast,
tyrosine phosphorylation of 2B4 was abolished completely in
NK cells from SAP  and Fyn /  mice (top, lanes 4–6). Simi-
larly, phosphorylation of SHIP was reduced in SAP  and ab-
rogated in Fyn /  mice (middle, lanes 4–6). These data indi-
cate that 2B4-mediated tyrosine phosphorylation signals are
impaired in SAP  and Fyn-deficient mice. They also argue
that in the absence of SAP, 2B4-mediated natural cytotoxicity
is impaired because 2B4 is uncoupled to Fyn.
DISCUSSION
In this study we showed that SAP-deficient and Fyn-defi-
cient mice exhibit an impaired natural cytotoxicity response
to tumor cells that express CD48. Because CD48 is the
ligand of 2B4, and none of the CD48-negative target cell
lines that we examined was killed via a SAP-dependent
pathway, we conclude that the defect in natural cytotoxicity
of SAP  NK cells resulted from a loss-of-function of 2B4.
However, SAP also binds to other SLAM family receptors,
and recent studies showed that SAP is required for the bio-
logic functions of at least three of these receptors, including
2B4, SLAM, and NTB-A. Therefore, one could argue that
the defect of SAP  NK cells is not restricted to 2B4. In ad-
dition to 2B4, murine NK cells were shown to express the
SLAM family receptors, CD84 and CRACC, but not
NTB-A, Ly9, and SLAM (unpublished data). Recent reports
showed that CRACC triggers cell cytotoxicity by human
NK cells, but that this activity does not require SAP (26).
This finding was explained by the inability of CRACC to
associate with SAP in humans and in mice (unpublished
data). The function of CD84 in NK cells is unknown. How-
ever, its seems to be similar to that of SLAM in T cells,
which consists of the regulation of TCR-mediated IFN- 
production (9). Accordingly, in mouse NK cells, 2B4 seems
to be the only SLAM family receptor expressed that is in-
volved in SAP-dependent cell cytotoxicity.
The impairment of the cytolytic activity of SAP  NK
cells is restricted to CD48-expressing tumor cells, although
this defect was variable, depending on the tumor cell line.
This variability could not be explained by differences in
CD48 expression between tumor cell lines, because all ex-
Figure 7. 2B4-mediated cell-cytotoxicity and IFN-  production by 
NK cells is impaired in the absence of Fyn. (A) The cytolytic activity of 
IL-2–expanded NK cells from wild-type (left) and Fyn /  mice (right) mice 
was measured in a RADCC assay. Experiment same as in Fig. 2. (B) 2B4-
mediated IFN-  production by IL-2-expanded NK cells. Experiment same 
as in Fig. 2. (C and D) Natural cytotoxicity in vitro against a panel of target 
cells is restricted in Fyn-deficient NK cells. (C) Cytolytic activity of IL-2–
expanded splenic NK cells from wild-type ( ) and Fyn /  ( ) mice against 
C4.4-25, RMA/S, RMA, or CHO target cells. Experiment same as in Fig. 1. 
(D) Cytolytic activity of IL-2–expanded splenic NK cells from wild-type 
(left) and Fyn /  (right) mice was tested in parallel against CL.1 and 
CL.1-CD48 target cells. Experiment same as in Fig. 5.JEM VOL. 202, July 4, 2005 189
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pressed similar magnitudes of CD48. These tumor cells also
expressed ligands other than CD48 that might trigger NK cell
cytotoxicity. The impact of 2B4 stimulation on NK cell acti-
vation probably depends on the nature of the other NK re-
ceptors engaged. YAC-1 cells express high level of ligands for
NKG2D, and YAC-1 cell lysis is mostly dependent on
NKG2D receptor activation (4, 6). Likewise, the lysis of BW
15.02 cells depends on activation of the stimulatory NK cell
receptor, NKp46 (3, 7). Presumably, in these cases, NK cells
are activated via the coengagement of 2B4 and NKG2D or
NKp46 receptors as it was reported previously for human
NK cells (28). In this context, NKG2D and NKp46 receptors
may play a predominant role and account for the slight de-
pendence of YAC-1 and BW 15.02 cells lysis on 2B4-medi-
ated NK cell cytotoxicity. By contrast, the lysis of RMA,
RMA/S, EL4, C4.4-25, and BaF/3 cells was heavily depen-
dent on 2B4 activation. Until now, the activating pathways
in NK cells involved in triggering the lysis of these target cells
were unknown. These tumor cells express no known
NKG2D ligands (4, 5), and a recent report showed that the
lysis of these tumor cells does not require ITAM-bearing NK
receptors because these cells normally are killed by Syk / 
ZAP-70 /  NK cells (8). These observations imply that in
the absence of activating ligands for NKG2D and ITAM-
bearing NK receptors, CD48 expression on tumors cells is a
major trigger of NK cell activation via a 2B4/SAP/Fyn path-
way. Along the same line, in patients who have XLP, defects
in 2B4-mediated antitumoral NK activity may account for
the appearance of lymphomas in 30% of patients (9, 21).
The mechanism by which 2B4 initiates signaling events is
distinct from that used by the NKG2D-DAP-10 receptor
complex and NK cell receptors associated with ITAM-bear-
ing subunits. The cell cytotoxicity triggered by NKG2D-
DAP-10 depends directly on the binding of PI3 kinase to
DAP-10 (1, 3). For ITAM-associated receptors, Syk/ZAP
protein tyrosine kinases are recruited to phosphorylated
ITAMs and are responsible for the propagation of downstream
signals. In T lymphocytes, we previously showed that SAP is
required for the function of SLAM by its capacity to promote
the selective recruitment and activation of the Src-PTK Fyn
(29). We and others have proposed that SAP might have a
similar role in the signal transduction via the other SLAM
family receptors. We recently provided evidence that SAP is
indeed involved in the recruitment of Fyn to 2B4 allowing by
this way 2B4-mediated tyrosine phosphorylation signals (20).
In this previous study, the association between Fyn and 2B4
was observed in a human NK cell line. In the present study,
we failed to detect 2B4-Fyn interaction in mouse NK cells. It
is possible that this association is less stable in mouse than in
humans. However, Fyn seems to be essential for 2B4 function
in mouse as NK cells from Fyn /  mice exhibit defective
2B4-mediated cell cytotoxicity. Intriguingly, in Fyn /  NK
cells, 2B4-mediated tyrosine phosphorylation signals was
found to be almost completely abolished while it was only de-
creased in SAP  NK cells suggesting SAP-independent role(s)
of Fyn. Fyn also is required for the function of other activating
NK cell receptors such as CD16 (Fc RIII) that may be en-
gaged by anti-2B4 antibodies via their Fc portion (27). One
other possibility is that Fyn is required for activating and in-
hibitory functions of 2B4. Our results strongly suggest that
2B4-mediated inhibition of cytotoxicity in Fyn /  NK cells is
defective (Fig. 7). Finally, it also is possible that Fyn is in-
Figure 8. Fyn and SAP are required for 2B4-mediated tyrosine 
phosphorylation signals. (A) Overall tyrosine phosphorylation. IL-2–
expanded splenic NK cells from wild-type, SAP , and Fyn /  mice were 
stimulated ( ) or not ( ) for 5 min with biotinylated anti-2B4 antibodies 
and avidin. Protein tyrosine phosphorylation was examined by immuno-
blotting of total cell lysates with anti-P.tyr antibody (top). The abundance 
of 2B4 in the lysates was verified by reprobing the membrane with anti-
2B4 antibodies (bottom). (B) Tyrosine phosphorylation of SHIP and 2B4. 
Experiment same as (A). Tyrosine phosphorylation of 2B4 (top) and SHIP 
(middle) was analyzed by probing anti-2B4 and anti-SHIP antibody immu-
noprecipitates (I.P.) with anti-P.tyr antibody. The abundance of 2B4 and 
SHIP was verified by reprobing the membranes with anti-2B4 and anti-
SHIP antibodies, respectively. (C) Expression of SAP and Fyn in NK cells 
from wild-type, SAP , and Fyn /  mice. Experiment same as (A) and (B). 
The abundance of SAP and Fyn was verified in total cell lysates by immu-
noblotting with anti-SAP (top) and Fyn (bottom) antibodies.CONTROL OF NATURAL CYTOTOXICITY BY SAP | Bloch-Queyrat et al. 190
volved in 2B4-mediated tyrosine phosphorylation of sub-
strates, such as LAT and PLC- 1, which seem not to depend
on SAP (20). In connection with that, we observed a weak
killing against CL.1 cells by the Fyn /  NK cells when com-
pared with that obtained with SAP  NK cells and wild-type
NK cells (Figs. 5 and 7). Similarly, a decreased killing against
P815 (Fig. 7), YAC-1, and B16-FO (not depicted) cells also
was noticed in the absence of Fyn. These effects could be also
explained by the fact that Fyn is involved in other activating
pathways in NK cells that do not depend on SAP, such as
those triggered by CD16 and DNAM-1, as mentioned above
(27, 30). These pathways may be required for efficient killing
of some target cells. Also, these observations are consistent
with recent studies that showed that the absence of Fyn results
in T cell activation defects that are more severe than those ob-
served in SAP-deficient T cells (31).
Our results clearly demonstrate that 2B4 behaves as an
inhibitory and an activating receptor, depending of the pres-
ence of SAP. The inability of SAP  NK cells to lyse CD48-
expressing target cells combines two effects: the loss of
2B4-mediated stimulatory signals and the ability of 2B4 to
mediate inhibitory signals in the absence of SAP that turn off
NK cell cytotoxicity. The first evidence for an inhibitory role
of 2B4 in the absence of SAP was provided by studies of pa-
tients with XLP, which showed that 2B4 has the capacity to
inhibit activating signals triggered by natural cytotoxicity re-
ceptors (16). Anti-2B4 antibodies also enhanced cell cyto-
toxicity of NK cells from patients who had XLP toward
EBV-infected cells, presumably by blocking 2B4-CD48 in-
teractions. Importantly, this inhibition could compromise
further the ability of NK cells of patients who have XLP to
eliminate EBV-infected cells or tumor cells. The inhibitory
function of 2B4 was supported further by the recent charac-
terization of mice lacking 2B4. 2B4-deficient NK cells ex-
hibited increased NK cell–mediated cytotoxicity and IFN- 
production (32, 33). However, in these studies, 2B4 was
shown to be primarily an inhibitory receptor, which could
be viewed as contradictory to our data and the data obtained
in humans. The dominant inhibitory effect of 2B4 in these
recent reports might be explained by a low expression of
SAP in NK cells that were used in these studies. Consistent
with this, the authors showed that bone marrow–derived
NK cells that lacked SAP RNA expression exhibited a
strong 2B4-mediated inhibition, whereas LAK cells that had
detectable SAP RNA showed a 2B4-mediated inhibition to
a lesser extent. Based on these observations and our data, it is
very likely that there is a threshold in SAP expression below
which the activating function of 2B4 is shifted toward inhi-
bition. SAP is expressed in limiting quantities in NK cells,
and small variations in the amount of SAP may change the
function of 2B4. This also is supported by the recent analysis
of NK cells from transgenic mice for SAP under the CD2
promoter. NK cells from these mice overexpress SAP and
have enhanced 2B4-mediated natural cytotoxicity (Veillette
et al., unpublished observations).
The molecular basis of the 2B4 inhibitory function is not
well-understood. Reports have shown that 2B4 has the ca-
pacity to associate with the protein tyrosine phosphatases,
SHP-1 and SHP-2, and that this interaction is blocked by
SAP (16, 34). However, these findings were not confirmed
in other studies (17, 26). Nonetheless, Src-homology 2–con-
taining inhibitory molecules may interact with 2B4 in the
absence of SAP. It should be pointed out that EAT-2, a
SAP-related protein, is expressed in NK cells (26, 32). Simi-
lar to SAP, EAT-2 has the capacity to bind to SLAM family
receptors, including 2B4 (18). Therefore, one possibility is
that when bound to 2B4, EAT-2 provided a signal that led
to the inhibition of NK cell activation. Additional studies are
needed to determine the precise biochemical mechanism by
which 2B4 inhibits NK activation.
Despite identification of the gene that is responsible for
XLP disease, the immune defects that cause XLP have not
been characterized unambiguously. In particular, susceptibil-
ity to EBV infection and hemophagocytic syndrome (HPS;
or virus-associated hemophagocytic syndrome) that occur in
most cases, are poorly understood. It was hypothesized that
this phenotype might stem from a defect in T helper (Th)
2–type responses (21, 22). As a consequence, Th1-type re-
sponses would be prolonged inappropriately, and hence,
could account for the excessive accumulation of activated
CD8  T cells and macrophages that occur in HPS. Studies
of SAP  mice confirmed that SAP is necessary for normal
Th2 responses (31, 35). However, one limitation of the
mouse model is that mice are not susceptible to EBV infec-
tion and do not develop HPS. The HPS observed in XLP
disease is very similar to that observed in the inherited im-
munodeficiencies that lead to defective cytotoxic functions
of CD8  T cells and NK cells (25). The molecular elucida-
tion of these diseases has highlighted the crucial role of T
and NK cell cytotoxic functions in immune homeostasis,
particularly after antiviral responses. Thus, because the loss of
cytotoxic functions leads to a defect in homeostatic balance
that results in HPS, one attractive possibility is that the
blocking of NK cytotoxicity by 2B4 could be one of the
major factors of HPS manifestations in XLP.
CD48 is expressed strongly on B cells when infected with
EBV. Notably, this molecule was described first 20 yr ago as a
specific marker of B cell transformation by EBV (13). It also
was reported that the increase in CD48 expression observed
during EBV infection was dependent on a regulatory element
in the CD48 promoter that is activated in the presence of
EBV (36). During EBV infection, the increased CD48 ex-
pression on EBV-infected B cells is likely to lead to the sus-
tained engagement of 2B4 on NK cells, and, possibly, on
CD8  T cells expressing 2B4 (23, 24). In a normal setting,
such stimulation of 2B4 would facilitate the elimination of in-
fected B cells by activating the cytolytic activities of NK cells
and maybe also CD8  T cells. Conversely, in patients who
have XLP, this would lead to an inhibition of NK cell cyto-
toxicity. Further experiments are required to test this model.JEM VOL. 202, July 4, 2005 191
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MATERIALS AND METHODS
Mice.  SAP-deficient (SAP ) and Fyn-deficient (Fyn / ) mice have been
described elsewhere (37, 38). SAP-deficient mice were backcrossed to
C57BL/6 mice for 10 generations. Male mice (SAP  and their SAP  litter-
mates) were used for experiments. C57BL/6 RAG-2 /  mice were ob-
tained from Charles River Laboratories. C57BL/6 RAG-2 /  c /  mice
were provided by F. Colucci (Institut Pasteur, Paris, France). All mice were
8–12 wk of age. Mouse studies were approved by the French Ministry of
Agriculture for Animal Experimentations.
Flow cytometry analysis. The following mAbs, unconjugated or conju-
gated to FITC, PE, or biotin were used in this study: anti-NK1.1, anti-
CD2, anti-2B4, anti-DX5, anti-CD16/CD32, anti-Ly49C/I, anti-
LY49G2, anti-Ly49A, anti-Ly49D, anti-CD45R, anti-CD3, anti-CD4,
anti-CD8, anti-CD19, anti-TCR , anti-H-2Kb, anti-H-2Db, and anti-
CD48 (all obtained from BD Biosciences). APC-Streptavidin and FITC-
conjugated secondary antibodies (FITC-conjugated goat anti–rat Ig or
FITC-conjugated rat anti–mouse Ig obtained from Jackson ImmunoRe-
search Laboratories) were used to reveal biotin-conjugated and nonconju-
gated antibodies, respectively. Low-affinity Fc  receptors were blocked
with 10  g/ml of 2.4G2 to prevent nonspecific binding.
Cells. YAC-1 (H-2a), RMA (H-2b), RMA/S (H-2b), EL4 (H-2b), C4.4-
25 (H-2b), Ba/F3 (H-2d), IC-21 (H-2b), BW51.05 (H-2b), B16-FO (H-2b),
P815 (H-2d), and CHO cell lines were grown in RPMI-1640–
GLUTAMAX supplemented with 10% FCS and antibiotics (all reagents
were obtained from GIBCO BRL). The CD48  cell lines, CL.1 and
CL.52, were obtained by the limiting dilution of C4.4-2 cells.
IL-2–expanded NK cells were obtained from splenocytes. T and B cells
were removed by passing splenocytes stained with PE-conjugated anti-CD3,
anti-CD4, anti-CD8, and anti-CD19 antibodies through magnetic columns
that were coated with anti-PE antibodies (Miltenyi Biotec). The splenic NK
cells were expanded in RPMI 1640–GLUTAMAX supplemented with 10%
FCS, antibiotics, 10 5 M  -mercaptoethanol (Sigma-Aldrich), and 1,000
IU/ml of recombinant IL-2 for 6–12 d. Greater than 98% of the cells ob-
tained with this protocol were CD3 , NK1.1 , 2B4 , and CD16 . No dif-
ferences in the expression patterns of 12 markers tested (including Ly49G2,
Ly49D, Ly49A, Ly49C/I, CD16, 2B4, CD2, CD45, DX5, NK1.1,
NKG2D, and CD3) were noticeable between IL-2–expanded splenic NK
cells from SAP , SAP , and Fyn /  mice (unpublished data).
cDNA constructs and transfections.  The mouse CD48 cDNA was
cloned from C57BL/6 thymocytes by RT-PCR using the following primers:
sense oligonucleotide: 5 -AGGAAGATGTGCTTCATAAAACAGGG-3 ;
antisense oligonucleotide: 5 -TTGTCAGGTTAACAGGATCCTGTG-3 .
The mouse CD48 cDNA was inserted into the vector pSR -Puro, which
contains the puromycin resistance gene. Stable transfectants expressing CD48
(CL.1-CD48 and CL.52-CD48) were obtained by selection in medium con-
taining puromycin (5  g/ml) as described previously (19).
Immunoprecipitation and immunoblots.  Immunoprecipitations and
immunoblots were performed as described previously (19, 20).
NK cell cytotoxicity in vitro assays.  The cytolytic activity of NK cells
was evaluated with a standard 4-h 51Cr release assay. In brief, target cells
(5   103) labeled with 51Cr were incubated with NK cells for 4 h at 37 C at
the indicated effector/target ratio. For RADCC assays, NK cells were incu-
bated with 5  g/ml of anti-2B4, anti-NK1.1, or anti-CD16 for 30 min at
4 C, washed, and then mixed with the P815 FcR -labeled target cells. The
percentage of specific lysis was calculated according to the standard formula:
(experimental   spontaneous release)/(total   spontaneous release). All as-
says were done in triplicate.
Cytokine production assays.  NK cells (6   104) were stimulated at
37 C with 5  g/ml of anti-2B4 or control anti–H-2Db antibodies (mouse
IgG2b), with IL-12 (5 ng/ml; Valbiotech), or in a RADCC assay (see previ-
ous paragraph). In brief, NK cells (6   104) were incubated with the P815
cells (6   103) in the presence of various concentrations of anti-2B4 antibod-
ies. After 24 h of stimulation, cell-free supernatants were collected and as-
sayed for IFN-  by ELISA (R&D Systems). All assays were done in triplicate.
In vivo tumor elimination. RMA cells (106) were labeled with the vital
dye PKH-26 (5  M) according to the protocol of the manufacturer (Sigma-
Aldrich). Cells were washed, resuspended in PBS, and injected into the
peritoneal cavity of mice. 24 h after the injection; mice were killed, and the
peritoneal cells were recovered, washed, and counted. The proportion of
cells that were PKH-26 positive was determined with a FACScan flow cy-
tometer (Becton Dickinson).
The elimination of CL.1 and CL.1-CD48 tumor cells was evaluated by la-
beling cells (107/ml) with the vital dye, CFSE (20  M, Molecular Probes), in
PBS for 15 min at room temperature. Cells were washed extensively, and equal
numbers of CFSE-labeled CL.1 and CL.1-CD48 cells were mixed in PBS
(1.5   106 of each cell type in a final volume of 300  l) and injected into the
peritoneal cavity. An aliquot of mixed cells was kept in culture. After 6 h, peri-
toneal cells were recovered, washed, counted, and stained with a PE-conju-
gated anti-CD48. As a control, the mixed cells that had been kept in culture
also were stained. Based on fluorescence, the percentages of CL.1-CD48 cells
(positive for CFSE and CD48) and CL.1 cells (positive for CFSE and negative
for CD48) among the peritoneal cells were determined by flow cytometry.
Data were acquired and analyzed with CellQuest software (Becton Dickinson).
NK cell counts in the peritoneal cavity were calculated from the per-
centage of NK cells among peritoneal cells as determined by flow cytometry
after staining with FITC-conjugated anti-2B4 and APC-conjugated anti-
NK1.1 antibodies. These cells were negative for CD3.
Statistical analysis.  Student’s t tests were performed with InStat software.
Online supplemental material. Fig. S1 shows the proportions of NK
cells in the thymus, bone marrow, liver, and spleen of wild-type and SAP-
deficient mice, and the expression NK cell receptors on splenic NK cells
from wild-type and SAP-deficient mice. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20050449/DC1.
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